Guangzhou RiboBio Partners with GE to Build Oligonucleotide CRO/CMO Facility Nov 21, 2017 Life Science
DelMar Presents Positive Interim Results from VAL-083 Study in MGMT-unmethylated Recurrent GBM at The Society for NeuroOncology Annual Meeting Nov 21, 2017 Life Science
Canada’s Acasti Signs $133 Million Non-Binding Term Sheet with China Pharma Nov 20, 2017 Life Science
Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell Therapy Has Been Granted Breakthrough Therapy Designation from FDA and Prime Eligibility from EMA for Relapsed and Refractory Multiple Myeloma Nov 17, 2017 Life Science
